|
Volumn 275, Issue 31, 2000, Pages 24065-24069
|
Wild-type but not Parkinson's disease-related Ala-53 → Thr mutant α-Synuclein protects neuronal cells from apoptotic stimuli
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ACETYLASPARTYLGLUTAMYLVALYLASPARTYL ALDEHYDE;
ALANINE;
ALPHA SYNUCLEIN;
AMYLOID BETA PROTEIN;
CASPASE;
CERAMIDE;
ETOPOSIDE;
MUTANT PROTEIN;
PEPTIDE DERIVATIVE;
STAUROSPORINE;
THREONINE;
UNCLASSIFIED DRUG;
APOPTOSIS;
ARTICLE;
AUTOSOMAL DOMINANT DISORDER;
CELL VIABILITY;
CONTROLLED STUDY;
ENZYME ACTIVITY;
GENE MUTATION;
HUMAN;
HUMAN CELL;
NERVE CELL NECROSIS;
NERVE DEGENERATION;
PARKINSON DISEASE;
PRIORITY JOURNAL;
PROTEIN AGGREGATION;
ADULT;
ALPHA-SYNUCLEIN;
APOPTOSIS;
CASPASES;
CERAMIDES;
CYSTEINE PROTEINASE INHIBITORS;
ETOPOSIDE;
HUMANS;
MUTATION;
NEOCORTEX;
NERVE TISSUE PROTEINS;
NEURONS;
NEUROPROTECTIVE AGENTS;
PARKINSON DISEASE;
STAUROSPORINE;
SYNUCLEINS;
TRANSFECTION;
|
EID: 0034604583
PISSN: 00219258
EISSN: None
Source Type: Journal
DOI: 10.1074/jbc.M002413200 Document Type: Article |
Times cited : (193)
|
References (38)
|